Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
TiumBio financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩5.9 K
2024-10-29
Market Capitalization
₩138.5 B
2024-10-29
Revenue
₩6.8 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 05, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|
| Revenue | 56.8M | 9.1B | 4.9B | 6.8B |
| Cost of goods sold | (1.0K) | |||
| Gross profit | 903.3M | 12.7B | 17.4B | 9.0B |
| Gross profit margin, % | 1590.3% | 139.3% | 355.5% | 132.8% |
| Operating expense total | 30.8B | 31.3B | 29.5B | 21.7B |
| Depreciation and amortization | 1.9B | 3.5B | 3.3B | 3.8B |
| EBITDA | (30.3B) | (19.9B) | (13.3B) | (1.5B) |
| EBITDA margin, % | -53333.0% | -218.1% | -271.9% | -22.1% |
| EBIT | (32.2B) | (23.4B) | (16.7B) | (5.3B) |
| EBIT margin, % | -56775.3% | -256.3% | -341.3% | -78.1% |
| Interest income | 919.3M | 1.3B | 1.2B | 479.9M |
| Interest expense | 518.5M | 808.4M | 2.5B | 4.0B |
| Pre tax profit | (32.3B) | (31.4B) | (19.0B) | (23.5B) |
| Net Income | (32.3B) | (31.4B) | (19.0B) | (23.5B) |